Phase II Trial Of Eltrombopag For Patients With Chronic Lymphocytic Leukemia (CLL) and Thrombocytopenia »
03/30/14

MD Anderson Cancer Center (MDACC) Score Adds Prognostic Information To The Distinction Between High COUNT Monoclonal B-CELL Lymphocytosis (HC-MBL) and RAI STAGE 0 Chronic Lymphocytic Leukemia (CLL) »
03/30/14

Analysis Of T Cell Receptor Repertoire Reveals Evidence For Antigen-Specific Response In CLL Lymph Nodes »
03/30/14

NK Cells Down-Regulation and Reversal With Lenalidomide »
03/30/14

Proteinkinase C-I2 Inhibitors sensitise Malignant B Cells To Cytotoxic Drugs »
03/30/14

B-Cell Anergy and indolent clinical behavior Of CLL »
03/30/14

Ibrutinib and nascent recovery of Humoral Immunity »
03/30/14

Old DAT / New Data : Positive Direct Antiglobulin Test »
03/30/14

Transcriptional Mistargeting Of NFAT2 »
03/30/14

Lymph Node Derived CLL Cells »
03/30/14